Ruxolitinib: Targeted Approach for Treatment of Autoinflammatory Very Early Onset Inflammatory Bowel Disease

Authors:

Abstract
No abstract available
Funding Information
  • NIH
  • National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK119585, R01 DK111843)

This publication has 8 references indexed in Scilit: